Literature DB >> 23725918

Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol.

Andrew J Juren1, Gautamn Sarwal, Ahmad Al-Sarraf, Michal Vrablik, Darren Chan, Karin H Humphries, Jiri J Frohlich.   

Abstract

BACKGROUND: Diabetes mellitus and low levels of high-density lipoprotein cholesterol (HDL-C) are among several known risk factors for coronary artery disease. Recent research has shown potential mechanistic links between these two diseases.
OBJECTIVES: The aim of our study was to characterize, by examining particular coronary artery disease risk factors, patients with extremely high and low levels of HDL-C who were referred to a prevention clinic.
METHODS: We compared the phenotypes of 113 patients with HDL-C levels greater than the 90th percentile with 212 patients with levels less than the 10th percentile by using a retrospective chart review.
RESULTS: The cohort with high HDL-C had a remarkable difference in the incidence of type 2 diabetes (1.8% vs 21.7%). The high HDL-C cohort also had a greater age (52.1 years vs 46.7 years), more light or moderate alcohol consumption (70.8% vs 49.4%), more healthy diet (30.1% vs 22.4%), more light or moderate exercise (90.8% vs 52.2%), and a lower body mass index (25.2 kg/m² vs 28.1 kg/m²).
CONCLUSIONS: Compared with the low HDL-C group--and also the general population--the high HDL-C cohort had a remarkably low prevalence of diabetes mellitus.
Copyright © 2013 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725918     DOI: 10.1016/j.jacl.2013.02.003

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  6 in total

1.  Targeted next-generation sequencing to diagnose disorders of HDL cholesterol.

Authors:  Singh N Sadananda; Jia Nee Foo; Meng Tiak Toh; Lubomira Cermakova; Laia Trigueros-Motos; Teddy Chan; Herty Liany; Jennifer A Collins; Sima Gerami; Roshni R Singaraja; Michael R Hayden; Gordon A Francis; Jiri Frohlich; Chiea Chuen Khor; Liam R Brunham
Journal:  J Lipid Res       Date:  2015-08-08       Impact factor: 5.922

2.  Hepatic transforming growth factor-β 1 stimulated clone-22 D1 controls systemic cholesterol metabolism.

Authors:  Julia Jäger; Vera Greiner; Daniela Strzoda; Oksana Seibert; Katharina Niopek; Tjeerd P Sijmonsma; Michaela Schäfer; Allan Jones; Roldan De Guia; Marc Martignoni; Geesje M Dallinga-Thie; Mauricio B Diaz; Thomas G Hofmann; Stephan Herzig
Journal:  Mol Metab       Date:  2014-01-08       Impact factor: 7.422

3.  High -density lipoprotein cholesterol as a predictor for diabetes mellitus.

Authors:  Hong Wu; Peng Ouyang; Wenjun Sun
Journal:  Caspian J Intern Med       Date:  2018

4.  Type 2 diabetes family histories, body composition and fasting glucose levels: a cross-section analysis in healthy sedentary male and female.

Authors:  Antonino Bianco; Francesco Pomara; Ewan Thomas; Antonio Paoli; Giuseppe Battaglia; Marco Petrucci; Patrizia Proia; Marianna Bellafiore; Antonio Palma
Journal:  Iran J Public Health       Date:  2013-07-01       Impact factor: 1.429

Review 5.  Diabetes and the metabolic syndrome: possibilities of a new breath test in a dolphin model.

Authors:  Michael Schivo; Alexander A Aksenov; Laura C Yeates; Alberto Pasamontes; Cristina E Davis
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-25       Impact factor: 5.555

6.  Decrease in HDL-C is Associated with Age and Household Income in Adults from the Korean National Health and Nutrition Examination Survey 2017: Correlation Analysis of Low HDL-C and Poverty.

Authors:  Kyung-Hyun Cho; Hye-Jeong Park; Suk-Jeong Kim; Jae-Ryong Kim
Journal:  Int J Environ Res Public Health       Date:  2019-09-10       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.